Salman, A. Et Al. 2022. Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis. DERMATOLOGIC THERAPY , vol.35, no.1 .

Salman, A., Sengun, O. A., Aktas, M., & Taskapan, O., (2022). Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis. DERMATOLOGIC THERAPY , vol.35, no.1.

Salman, ANDAÇ Et Al. "Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis," DERMATOLOGIC THERAPY , vol.35, no.1, 2022

Salman, ANDAÇ Et Al. "Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis." DERMATOLOGIC THERAPY , vol.35, no.1, 2022

Salman, A. Et Al. (2022) . "Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis." DERMATOLOGIC THERAPY , vol.35, no.1.

@article{article, author={ANDAÇ SALMAN Et Al. }, title={Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis}, journal={DERMATOLOGIC THERAPY}, year=2022}